 |
Previous Article | Next Article 
The Journal of Neuroscience, June 1, 1998, 18(11):4374-4383
Axotomy Upregulates the Anterograde Transport and Expression of
Brain-Derived Neurotrophic Factor by Sensory Neurons
James R.
Tonra,
Rory
Curtis,
Vivien
Wong,
Kenneth D.
Cliffer,
John S.
Park,
Andrew
Timmes,
Trang
Nguyen,
Ronald M.
Lindsay,
Ann
Acheson, and
Peter
S.
DiStefano
Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591
 |
ABSTRACT |
In addition to the known retrograde transport of neurotrophins, it
is now evident that endogenous brain-derived neurotrophic factor (BDNF)
is transported in the anterograde direction in peripheral and central
neurons. We used a double-ligation procedure that distinguishes between
anterograde and retrograde flow to quantify the anterograde transport
of endogenous neurotrophins and neuropeptides in the peripheral nervous
system before and after axotomy. BDNF accumulation proximal to the
ligation (anterograde transport) was twice that distal to the ligation
(retrograde direction). Anterograde transport of nerve growth factor
and neurotrophin-3 was not evident. Furthermore, BDNF anterograde
transport increased 3.5-fold within 24 hr after sciatic nerve injury or
dorsal rhizotomy. Anterograde transport of substance P and calcitonin
gene-related peptide decreased after peripheral nerve lesion,
demonstrating that there was no generalized increase in anterograde
transport. To determine the source of the anterogradely transported
BDNF, we performed in situ hybridization in a variety of
tissues before and after axotomy. Expression of BDNF mRNA in proximal
nerve segments did not change with treatment, showing that the
increased accumulation of BDNF was not a result of increased local
synthesis. BDNF mRNA and protein were expressed by dorsal root ganglion
sensory neurons but not by motor neurons. BDNF mRNA expression was
increased 1 d after nerve injury, and BDNF protein was also
increased twofold to threefold, suggesting that sensory neurons are the
major contributing source of the increased BDNF traffic in the sciatic
nerve. Our results suggest that increased anterogradely transported
BDNF plays a role in the early neuronal response to peripheral nerve injury at sites distal to the cell body.
Key words:
anterograde transport; retrograde transport; neurotrophin; BDNF; sciatic nerve; dorsal root ganglion
 |
INTRODUCTION |
The neurotrophins nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3), and NT-4 are produced by neuronal target tissues and regulate
the survival and normal maintenance of neurons (for review, see
Barbacid, 1994 ; Snider, 1994 ). The uptake of neurotrophins into axons
by high-affinity receptors is followed by retrograde transport to the
cell bodies of responsive neurons (DiStefano et al., 1992 ; Curtis et
al., 1995 ). Although it is generally accepted that retrograde transport is critical to neurotrophin function, the exact mechanism of action remains unknown (Curis and DiStefano, 1994 ). The expression of NT-3 and
BDNF in sensory neurons of the dorsal root ganglion (DRG) suggests that
the neurotrophins serve roles other than conventional target-derived
retrograde signaling factors (Ernfors et al., 1990 ; Schecterson and
Bothwell, 1992 ; Wetmore and Olson, 1995 ). The possibility of autocrine
or paracrine roles within the ganglion is supported by the observation
that DRG neurons in tissue culture produce BDNF that is required for
their own survival (Acheson et al., 1995 ). The production of BDNF by
sensory neurons also raises the possibility that the neurotrophins are
anterogradely transported and may influence target tissues or glial
cells. Trafficking of neurotrophins to sites distal to the cell body
would suggest new mechanisms of neurotrophin action.
There is mounting evidence for anterograde axonal transport of BDNF.
Exogenous 125I-labeled BDNF is anterogradely transported by
specific nuclei in the avian CNS (von Bartheld et al., 1996 ; Johnson et
al., 1997 ). Anterograde transport of endogenous BDNF in the rat CNS is
suggested by the presence of BDNF immunoreactivity in brain regions
devoid of BDNF mRNA and by the abolition of BDNF in these regions by deafferentation (Altar et al., 1997 ; Conner et al., 1997 ). In the
peripheral nervous system, interruption of axonal transport by ligation
of the sciatic nerve or crush of the dorsal root causes accumulation of
BDNF immunoreactivity proximal to the injuries, supporting both
peripheral and central anterograde transport by DRG neurons (Zhou and
Rush, 1996 ; Michael et al., 1997 ). The potential sources of BDNF
accumulation in sciatic nerve are DRG sensory neurons, target tissues,
or Schwann cells within the nerve, all of which can express BDNF under
certain circumstances (Ernfors et al., 1990 ; Meyer et al., 1992 ;
Schecterson and Bothwell, 1992 ; Henderson et al., 1993 ).
In this study, we have used immunohistochemistry and a sensitive ELISA
to localize and quantify BDNF anterograde transport in sciatic nerve.
In contrast to BDNF, we find no evidence for anterograde transport of
NGF or NT-3. We show by in situ hybridization that the
primary site of BDNF synthesis is DRG sensory neurons. Furthermore, we
demonstrate that the anterograde transport of BDNF is rapidly
upregulated when the peripheral nerve or dorsal roots are damaged, and
this correlates with increased expression of BDNF by sensory neurons.
The increased anterograde transport of BDNF after axonal injury
implicates this mode of neurotrophin action in the neuronal response to
peripheral nerve damage and suggests several novel functions for this
member of the neurotrophin family.
 |
MATERIALS AND METHODS |
Surgical procedures. Male Sprague Dawley rats
(250-400 gm) were obtained from Zivic Miller (Zelienople, PA), housed
two per cage, and given food and water ad libitum. Except
where otherwise noted, all rats were anesthetized with ketamine (50 mg/kg) and xylazine (10 mg/kg). All animal use in this study was
conducted in compliance with approved institutional animal care and use protocols and according to National Institutes of Health guidelines (Guide for the Care and Use of Laboratory Animals, National
Institutes of Health publication 86-23, 1985).
To axotomize peripheral axonal processes of sensory and motor neurons,
the sciatic nerve was crushed or cut at the level of the knee; either
the right sciatic nerve was crushed twice for 10 sec with number 5 fine
forceps, or a 5 mm segment was resected. Sham surgeries only exposed
the nerve. Dorsal rhizotomy was performed to damage the central axonal
processes of sensory neurons. L4 and L5 roots and DRGs were the focus,
because 97% of DRG neurons projecting into the sciatic nerve in the
rat are located in the L4 and L5 DRG (Swett et al., 1991 ). Briefly,
rats were anesthetized with chloral hydrate (170 mg/kg) and
pentobarbital (35 mg/kg), and a laminectomy was performed at the level
of the L2 DRG to expose the passing roots on the right side. After
opening the dura, the roots were cut and separated with gel foam. At
the time of killing it was verified that the L4 and L5 dorsal roots
were cut without damage to the ventral roots. Sham surgeries only
exposed the dura. After all surgeries, the muscle layers were sutured, and the skin was closed with surgical staples.
To visualize and quantify anterograde and retrograde transport of
endogenous neurotrophins and neuropeptides, we performed a
double-ligation procedure that has been used previously to examine axonal transport of acetylcholinesterase, neurotransmitters, and neurotrophins in the sciatic nerve (Ranish and Ochs, 1972 ; Ben-Jonathan et al., 1978 ; Johnson et al., 1987 ; Zhou and Rush, 1996 ). Ligations consisted of two 4-0 silk ligatures tied tightly around the sciatic nerve 0.5 cm apart, ~1 cm distal to the tendon of the obturator internus muscle. Eighteen to 20 hr later, the ligated nerve was removed
for immunostaining or biochemical analysis as described below. We used
the double-ligation technique for the following reasons: (1) it
interrupts axonal flow, facilitating visualization and quantification
of transported substances; (2) it provides clear separation of proximal
and distal segments, demonstrating retrograde or anterograde transport
of substances by accumulation in these segments; (3) accumulation on
the proximal side provides evidence for anterograde transport, whereas
accumulation on the distal side indicates retrograde transport; and (4)
the middle segment provides information about local synthesis as well
as accumulation after placement of the ligature. Although small amounts of a substance in transit within the middle segment may accumulate at
the ligations, local synthesis is suggested by uniform distribution throughout the middle segment.
125I-labeled BDNF was used to evaluate uptake and
anterograde or retrograde transport of BDNF from within the sciatic
nerve. 125I-BDNF was prepared and formulated according to
DiStefano et al. (1992) . Twenty-two nanograms of 125I-BDNF
in 0.5 µl were injected 14-16 mm proximal or distal to a single
ligature placed on the sciatic nerve under ketamine and xylazine
anesthesia. Twenty hours later the nerve between the injection site and
ligation was divided into 2 mm segments, and the 125I-BDNF
content was quantified by gamma counting.
Immunohistochemistry. Animals were anesthetized and perfused
transcardially with ice-cold heparinized saline followed by ice-cold 2% paraformaldehyde and 15% picric acid in 0.1 M
phosphate buffer, pH 6.9. Ligatures were removed, and the nerves were
equilibrated at 4°C for at least 48 hr in 25% sucrose and 0.1 M phosphate buffer with 0.008% sodium azide. Frozen
sections were cut at 10 µm on a cryostat, mounted on slides, and
incubated overnight at 4°C with various antibodies diluted in 0.1 M phosphate buffer and 0.3% Triton X-100. A specific goat
anti-NGF antiserum was a gift from Dr. E. M. Johnson Jr.
(Washington University, St. Louis, MO) (Anderson et al., 1995 ). A
rabbit polyclonal antibody against BDNF was provided by Amgen, Inc.
(Thousand Oaks, CA). This antibody is specific for BDNF because it
recognizes BDNF but not the other neurotrophins by ELISA (Radka et al.,
1996 ). Furthermore, BDNF immunoreactivity is absent in tissues from
BDNF-null mice, as shown by immunohistochemistry and ELISA (Bianchi et
al., 1996 ; Radka et al., 1996 ; Conner et al., 1997 ). Rabbit polyclonal
antisera against substance P (SP; Incstar, Stillwater, MN) or
calcitonin gene-related peptide (CGRP; Zeneca, Macclesfield, UK) were
gifts from Dr. Lorne M. Mendell (State University of New York, Stony Brook, NY). Staining was visualized with biotinylated rabbit anti-goat IgG (diluted 1:500) or biotinylated goat anti-rabbit IgG (diluted 1:200) and the ABC Elite kit for NGF and Standard kit for BONF, CGRP,
and SP (Vector, Burlingame, CA), using 3,3'-diaminobenzidine (Sigma,
St. Louis, MO) as the chromogen.
In situ hybridization. Plasmid containing full-length
rat BDNF cDNA (Maisonpierre et al., 1991 ) was linearized with either EcoRI for synthesis of antisense BDNF probes using T3
polymerase or KpnI for synthesis of sense BDNF probes using
T7 polymerase. 35S-UTP-labeled probes were produced with a
Stratagene (La Jolla, CA) RNA transcription Kit. Ten micrometer frozen
sections of DRG, spinal cord, and ligated nerve were fixed with 4%
paraformaldehyde for 10 min, acetylated, and hybridized as described
(Friedman et al., 1992 ). Slides were dipped in NTB-2 autoradiographic
emulsion (Kodak, Rochester, NY) and exposed at 4°C for 3-10 d.
ELISA and radioimmunoassay. Ligatures were removed, and the
nerves were cut into proximal, middle, and distal segments ~5 mm
long. DRGs were dissected free of the nerve and roots. The tissues were
weighed and frozen on dry ice. Before assay, tissues were homogenized
using a rotating Teflon pestle (1800 rpm) for 20 sec. In some
experiments, the results are expressed relative to tissue mass. In
other experiments, notably the measurement of neurotrophins and
neuropeptides before and after axotomy (see Fig. 3), protein assay was
performed on the nerve segments (Pierce, Rockford, IL), and the results
are expressed as nanograms per milligram of protein.
NGF, BDNF, and NT-3 were quantified in tissue extracts by two-site
ELISA. The NGF ELISA was performed with a commercially available kit
using the monoclonal antibody 27/21 (Boehringer Mannheim, Mannheim,
Germany). For the BDNF and NT-3 ELISAs, tissues were homogenized and
prepared as described, and the BDNF levels were determined using a
monoclonal antibody for capture and a biotinylated polyclonal reporter
antibody (Radka et al., 1996 ). NT-3 levels were determined using a
two-site ELISA that used different capture and reporter monoclonal
antibodies. Monoclonal antibodies were generated against recombinant
human NT-3 by conventional techniques. The linear ranges of the ELISAs
were BDNF, 78 pg/ml-10 ng/ml; NT-3, 78 pg/ml-20 ng/ml; and NGF, 0.1 pg/ml-11 ng/ml. The antibodies used in these ELISAs were specific for
the individual neurotrophins and did not cross-react with other
neurotrophin family members at up to 100 times the maximal
concentration used for the standard curve (Radka et al., 1996 ; A. Acheson, unpublished observations).
SP and CGRP radioimmunoassays were performed as described (Wong and
Kessler, 1987 ), using rabbit anti-SP antiserum (a gift from Dr. J. Kessler, Albert Einstein College of Medicine, Bronx, NY) or
commercially available kits for CGRP (Peninsula Laboratories Inc., Belmont, CA).
Data analysis. Differences in means were tested using ANOVA
with Fisher's protected least significant difference as a post hoc test; p < 0.05 was considered statistically
significant.
 |
RESULTS |
Retrograde but not anterograde transport of NGF
We have characterized previously the retrograde transport of
exogenous 125I-labeled neurotrophins to sensory and motor
neurons and the regulation of retrograde transport by neuronal injury
(DiStefano et al., 1992 ; DiStefano and Curtis, 1994 ; Curtis et al.,
1995 ). To examine the transport of endogenous neurotrophins in the
retrograde and/or anterograde direction, we used a double-ligation
technique. Accumulation of a substance on the proximal (cell body) side
provides evidence for anterograde transport from neurons in the spinal
cord or DRG whereas accumulation on the distal (peripheral) side of the
double ligature supports retrograde transport. To validate this
approach, we examined NGF accumulation by immunohistochemistry and
ELISA 18-20 hr after placement of the double ligation. In accordance with previous studies (Palmatier et al., 1984 ; Korsching and Thoenen, 1985 ), NGF immunoreactivity was visible on the distal side of the
distal ligature and to a lesser extent on the distal side of the
proximal ligature (Fig.
1A,B); NGF retrograde
transport but not anterograde transport was verified by
quantitative NGF ELISA (Fig. 1C).

View larger version (43K):
[in this window]
[in a new window]
|
Figure 1.
Endogenous NGF is transported retrogradely but not
in the anterograde direction. A, B, Immunohistochemical
staining of NGF accumulation over 18-20 hr proximal
(A) and distal (B) to a
double ligation. The middle segment of the double ligation is shown in
A, right, and B,
left. C, NGF levels in untreated sciatic
nerve (control) and in segments proximal or
distal to an 18-20 hr double ligation. Values represent the mean ± SEM. *p < 0.01 versus control. Scale bar, 0.5 mm.
|
|
Anterograde transport of BDNF is increased by neuronal injury
We next examined the transport of endogenous BDNF in the sciatic
nerve using a BDNF-specific antibody (see Materials and Methods). When
the sciatic nerve was removed immediately after placement of a double
ligation, BDNF immunoreactivity was not visualized on either side of
the ligature (Fig.
2A-C). However, BDNF
was localized on the proximal and distal sides of a double ligation after 18-20 hr (Fig. 2D-F). BDNF was
particularly intense on the proximal side, suggesting a predominance of
anterograde transport. The accumulation of BDNF proximal to the
ligature resembled the distribution of neuropeptides SP and CGRP (Fig.
2M,N), which are known to be anterogradely
transported in the axons of DRG neurons (Kruger et al., 1985 ;
Ishida-Yamamoto et al., 1989 ).

View larger version (136K):
[in this window]
[in a new window]
|
Figure 2.
Immunohistochemical staining of endogenous BDNF
(A-L) in rat sciatic nerve proximal and distal
to a double ligation. In the low power micrographs (A, D, G,
J), the proximal (central) side is
left and the distal (peripheral) side is
right. Higher-magnification photomicrographs show proximal nerve
segments (B, E, H, K) illustrating anterograde
transport or distal segments (C, F, I, L) showing
retrograde transport. A-C, Nerve removed immediately
after ligation; D-F, 18-20 hr after ligation in
untreated rats; G-I, 18-20 hr after ligation in rats
whose sciatic nerve was crushed 1 d earlier; J-L,
18-20 hr after ligation in rats 1 d after rhizotomy.
Immunohistochemical staining of SP (M) and
CGRP (N) in proximal segment 18-20 hr after
ligation in untreated rats is shown. Scale bars: A (for
A, D, G, J), 1 mm; B (for all
others), 100 µm.
|
|
We have reported previously that retrograde transport of exogenous
neurotrophins is modulated by neuronal injury (DiStefano and Curtis,
1994 ). To examine the effects of injury on anterograde and retrograde
transport of endogenous BDNF, a double ligation was placed on the
sciatic nerve proximal to a crush injury of the nerve made 1 d
earlier or 1 d after cutting L4 and L5 dorsal roots. The
accumulation of BDNF proximal to the ligation over the standard 18-20
hr period increased dramatically both after sciatic crush (Fig.
2G-I) and after rhizotomy (Fig.
2J-L). Taken together, these immunohistochemical
results support both the retrograde and anterograde transport of
endogenous BDNF in the sciatic nerve, as reported previously (Zhou and
Rush, 1996 ), and show that anterograde transport of BDNF is increased
after damage to either the dorsal roots or sciatic nerve.
The immunohistochemical results were corroborated using a sensitive
two-site ELISA for BDNF in the different nerve segments (Fig.
3A). Baseline BDNF content was
measured in nerve segments removed immediately after double ligation to
account for nonspecific effects of nerve manipulation. BDNF levels were
30 times greater than baseline levels in the proximal nerve segment and
13 times greater in the distal nerve segment 18-20 hr after double
ligation. In agreement with the immunohistochemistry, BDNF accumulation proximal to the ligations in these control nerves was significantly greater than in the distal nerve (p < 0.0001),
showing that the anterograde transport of BDNF is greater than
retrograde transport. BDNF levels in the segment of nerve between the
two ligations (middle) were not significantly different from baseline,
indicating a lack of local BDNF production. The local BDNF
concentration in the proximal segment (~2 × 10 9 M) can be calculated from the
total amount of BDNF that builds up at the ligature (~800 pg) and the
approximate volume of the tissue (16 µl, 5 mm nerve segment assuming
a diameter of 2 mm).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 3.
Quantification of endogenous neurotrophin and
neuropeptide levels in proximal, middle, and distal segments of rat
sciatic nerve subsequent to a double ligation. The diagram illustrates
the nerve segments removed from the ligated nerve. A,
BDNF; B, NT-3; C, SP; D,
CGRP. Nerve was removed immediately after ligation
(Baseline), 18-20 hr after ligation in untreated rats
(Control), or 18-20 hr after ligation after
rhizotomy (Rhizotomy) or sciatic crush
(Crush) 1 d previously. Values represent the
mean ± SEM of five or six rats for BDNF and NT-3 and three
animals for SP and CGRP. Note the different scales for each graph.
*p < 0.01 versus control;
#p < 0.05 versus baseline.
|
|
When the double ligation was placed on the sciatic nerve 1 d after
crushing the nerve distal to the ligation site or cutting the L4 and L5
dorsal roots, the accumulation of BDNF proximal to the ligations was
increased by ~3.5-fold compared with control values (Figs.
3A, 4). This did not reflect an overall increase in protein
in the nerve, because identical results were obtained when BDNF levels
were expressed relative to the tissue weight or protein content. Nerve
crush and rhizotomy did not change the BDNF levels in the middle
segment, indicating a lack of local BDNF synthesis 1 d after
neuronal injury. Transport in the retrograde direction was not
increased 1 d after rhizotomy. It is difficult to assess the
effects of nerve crush on retrograde transport with this paradigm,
because nerve injury distal to the ligatures separated the nerve from
potential sites of BDNF acquisition from the peripheral target tissues
(Schecterson and Bothwell, 1992 ; Henderson et al., 1993 ).
Baseline levels of NT-3 were higher than BDNF in all nerve segments
(Fig. 3B), consistent with NT-3 mRNA expression in the normal nerve (Funakoshi et al., 1993 ). NT-3 levels in the proximal, middle, and distal nerve segments were greater than baseline values 18-20 hr after double ligation. In contrast to BDNF, there were no
significant differences between segments, indicating that NT-3 levels
were probably increased by local synthesis, although it remains
possible that some NT-3 had accumulated by retrograde or anterograde
transport. NT-3 levels in the nerve segments were also not
significantly altered by either previous nerve crush or rhizotomy.
Therefore, the anterograde and retrograde transport of BDNF and the
regulation of BDNF anterograde transport by nerve injury set this
neurotrophin apart from NT-3 and NGF.
To test whether the increase in BDNF anterograde transport was linked
to a general increase in anterograde transport, we quantified the
accumulation of SP and CGRP at the double ligation in normal animals
and after nerve crush. SP and CGRP both accumulated at the proximal
side of an 18-20 hr double ligation but, unlike BDNF, the accumulation
was decreased 1 d after crushing the sciatic nerve (Fig.
3C,D). The decreased accumulation at the ligation was not
associated with a change in the total protein content in the DRG
(p > 0.7 for SP and CGRP, one-way ANOVA). These
results are in agreement with the reported lack of changes in the level of SP (Jessell et al., 1979 ) and CGRP (Dumoulin et al., 1991 ) in rat
DRG 1 d after sciatic nerve transection. Therefore, neuronal injury does not cause a general increase in anterograde transport of
axonally transported proteins.
To examine the time course of the effect of axonal injury on BDNF
anterograde transport, double ligatures were made 1-3 d after crushing
the sciatic nerve or cutting the dorsal roots. Whereas BDNF anterograde
transport was elevated 1 d after nerve crush, the accumulation of
BDNF proximal to the ligature returned to control levels at 2 and 3 days (Fig. 4). In contrast, the proximal accumulation of BDNF remained elevated up to 3 d after dorsal rhizotomy. Sham surgeries for the nerve crush and dorsal rhizotomy did
not significantly increase the anterograde transport of BDNF (Fig.
4).

View larger version (17K):
[in this window]
[in a new window]
|
Figure 4.
Time course of BDNF anterograde transport after
peripheral or central axotomy. Endogenous BDNF was measured in the
nerve segment proximal to an 18-20 hr double ligation of the sciatic
nerve. Ligations were performed on untreated rats
(Control) or 1, 2, and 3 d after rhizotomy
(Rhizotomy) or sciatic crush (Crush). To
control for the effects of surgical intervention, BDNF was also
measured in ligated nerve after sham crush and sham rhizotomy. Data
represent mean ± SEM of four or five animals.
|
|
Source of anterogradely transported BDNF
Potential sources of the BDNF proximal to a ligation are DRG
sensory neurons, motor neurons, or Schwann cells within the nerve. To
resolve this, we used in situ hybridization to localize BDNF mRNA expression before and after neuronal injury. BDNF mRNA was observed in DRG sensory neurons from untreated rats (Fig.
5A), and expression was
increased 1 d after crushing or cutting the sciatic nerve (Fig.
5C,E, respectively). Nerve injury increased the number of
neurons in the DRG expressing BDNF mRNA and also elevated the signal
from individual neurons. BDNF mRNA expression also increased 1 d
after dorsal rhizotomy but not after sham surgery to the nerve or
dorsal root (data not shown). Therefore, damage to the central or
peripheral process of DRG neurons upregulates BDNF mRNA in these cells
at a time when anterograde transport of BDNF into the peripheral
processes is also upregulated.

View larger version (200K):
[in this window]
[in a new window]
|
Figure 5.
BDNF in situ hybridization in L5
DRG, spinal cord, and sciatic nerve proximal to a ligation.
A, Untreated DRG; B, sense strand
hybridization control of ipsilateral DRG 1 d after sciatic crush;
C, D, ipsilateral and contralateral DRG, respectively,
1 d after sciatic crush; E, F, ipsilateral and
contralateral DRG, respectively, 1 d after cutting the sciatic
nerve; G, H, ipsilateral and contralateral ventral horn,
respectively, 1 d after cutting the sciatic nerve;
I, sense strand hybridization control of nerve segment
proximal to an 18-20 hr double ligation; J, proximal
nerve segment removed immediately after placement of a double ligation;
K, proximal nerve segment removed 18-20 hr after
ligation of the sciatic nerve 1 d after sciatic nerve crush distal
to the ligation site. Scale bar, 100 µm.
|
|
In contrast to the DRG, BDNF mRNA was not detected in motor neurons in
the ventral horn of the spinal cord in normal animals or 1 d after
cutting (Fig. 5G,H) or crushing (data not shown) the
sciatic nerve. To demonstrate the contribution of Schwann cells to the
BDNF measured in the proximal segments, we also examined BDNF mRNA
expression proximal to the ligations. BDNF mRNA expression, although
apparent in Schwann cells, was unchanged 18-20 hr after ligation, with
or without previous nerve lesion (Fig. 5K,J, respectively). Thus, local synthesis of BDNF by Schwann cells does not contribute to
the increased proximal accumulation of BDNF in the nerve. The sense
strand showed no hybridization in DRG or nerve (Fig.
5B,I).
In situ hybridization results show that BDNF can be
synthesized in nerve. Thus, it is conceivable that BDNF might be taken up by axons from within the nerve at a site proximal to the ligations, and be anterogradely transported. To test this possibility, we determined whether exogenous 125I-labeled BDNF injected
into the nerve proximal to a ligation could be bound, endocytosed, and
anterogradely transported by axonal processes. Retrograde and
anterograde transport of exogenous BDNF was investigated in sciatic
nerve with or without nerve crush. One day after crushing the nerve
distally, a single ligature was placed on the sciatic nerve proximal to
the crush, and 125I-BDNF was injected (0.5 µl volume)
14-16 mm proximal or distal to the ligature (diagrams in Fig.
6). Both the ligation and injection were
made proximal to the crush site. Approximately 20 hr after the
injection, the portion of the nerve between the injection site and
ligation was removed and divided into 2 mm nerve segments for gamma
counting. We have shown that, 18-20 hr after injection into the
sciatic nerve, > 90% of the 125I-BDNF remains intact (R. Curtis and P. S. DiStefano, unpublished data). After distal
injection, there was build up of 125I-BDNF at the ligature,
demonstrating that axons can take up and retrogradely transport BDNF
present in the nerve as expected (Fig. 6B).
Retrograde accumulation of BDNF was enhanced by previous nerve crush
compared to sham surgery. In contrast, there was no buildup of
125I-BDNF at the ligation site after proximal injection
either with previous nerve crush or sham surgery (Fig.
6A), supporting the conclusion that BDNF produced
within the nerve is not the source of anterogradely transported
BDNF.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 6.
Exogenous 125I BDNF injected into the
sciatic nerve is retrogradely but not anterogradely transported. The
nerve was crushed (shaded bars) or sham crushed
(solid bars) 24 hr earlier. 125I-BDNF
injections were made 14-16 mm proximal (A, anterograde
transport) or distal (B, retrograde transport) to a
single ligation of the sciatic nerve, as indicated. The nerve was
removed ~20 hr after injection, cut into 2 mm nerve segments, and
counted in a gamma counter. Data represent mean counts per minute
(CPM) ± SEM of three animals. Note that the
y-axis has been truncated at 28,000 CPM to illustrate
125I BDNF levels at the ligation site. 125I
BDNF levels at the injection site were 100,000-150,000 CPM.
*p < 0.05; **p < 0.01 versus
the adjacent segment 4 mm from the ligature.
|
|
From these results, it is likely that DRG sensory neurons are the major
contributing source of anterogradely transported BDNF both before and
after injury. To confirm this, we measured BDNF protein levels by ELISA
in the DRG before and after neuronal injury. BDNF levels in the
ipsilateral DRG were increased approximately twofold to threefold
1 d after sciatic nerve crush or rhizotomy (Fig.
7; two-way ANOVA, F(1,27) = 14.368; p = 0.0008). BDNF levels were not increased in
the contralateral DRG by any manipulations. These data suggest that
BDNF mRNA is translated into protein, but quantitative comparisons are
difficult because of the likely anterograde and retrograde trafficking
of BDNF through the ganglion.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 7.
BDNF levels are increased after axotomy.
Endogenous BDNF was measured by ELISA in the right DRG
(Ipsilateral) and left DRG
(Contralateral) from untreated animals
(Control) or 1 d after rhizotomy
(Rhizotomy), sciatic crush (Crush), or
sham crush (Sham Crush). Values represent the mean ± SEM of three to five animals and are representative of two
experiments in the case of crush and sham crush.
|
|
 |
DISCUSSION |
The target-derived model of neurotrophin action has recently been
supplemented by the concept that neurons themselves express neurotrophins (Ernfors et al., 1990 ; Schecterson and Bothwell, 1992 ).
Neuronal neurotrophins may act in a paracrine or autocrine manner on
neurons within the same ganglion or nucleus (Acheson et al., 1995 ;
Wetmore and Olson, 1995 ). The demonstration of anterograde transport
further alters this model, suggesting neurotrophic actions on distant
neurons or other target tissues. We have demonstrated increased
anterograde transport of BDNF in response to neuronal injury, thus
implicating BDNF in the process of nerve regeneration.
Source of BDNF
We have presented several lines of evidence that BDNF is
anterogradely transported in the sciatic nerve and that this transport is increased after nerve injury. As expected of an anterogradely transported protein, BDNF accumulated proximal to a double ligation of
the sciatic nerve over 18-20 hr. Moreover, the distribution of BDNF in
axons overlapped with the anterogradely transported neuropeptides SP
and CGRP. A sensitive two-site ELISA confirmed the immunohistochemical
results, showing that BDNF protein levels at the proximal ligature
increased 30-fold over baseline during the 18-20 hr ligation period.
In situ hybridization showed that BDNF mRNA expression was
not changed in this region after 20 hr of ligation, arguing against
local production of BDNF by Schwann cells as the source of the
accumulated BDNF. This is consistent with previous results that BDNF
mRNA expression is not increased until 3-7 d after sciatic nerve
injury in adult rats (Meyer et al., 1992 ; Funakoshi et al., 1993 ).
Finally, BDNF anterograde transport was increased after axotomy of DRG
neurons by either sciatic nerve crush or dorsal rhizotomy, which is
correlated with increased expression of BDNF mRNA and protein in the
DRG neurons (see below).
There are three potential sources of the anterogradely transported
BDNF. First it is possible that BDNF synthesized in peripheral target
tissues, and retrogradely transported to the DRG, is anterogradely transported back along the peripheral axons. Although we have not been
able to exclude this possibility, peripheral administration of a BDNF
antisera that blocks retrograde BDNF transport does not block the
anterograde transport of BDNF (Zhou and Rush, 1996 ). Second, it is
conceivable that BDNF released by Schwann cells in the nerve is taken
up into axons and anterogradely transported. We have shown that
exogenous 125I-BDNF injected into the sciatic nerve
proximal to a ligature did not result in accumulation, suggesting that
BDNF in the nerve cannot be taken up and transported anterogradely. The
third possibility, which we favor, is that DRG neurons are the source
of the anterogradely transported BDNF. In situ hybridization
showed relatively high BDNF mRNA levels in a defined subset of DRG
neurons (Ernfors et al., 1990 ; Schecterson and Bothwell, 1992 ; Kashiba
et al., 1997 ). Injury to either the central or peripheral process of
sensory neurons caused an upregulation of BDNF mRNA in these cells
within 1 d. Additionally, we have shown increased levels of BDNF
protein by ELISA, consistent with increased BDNF mRNA in DRG 1 d
after sciatic nerve injury (Sebert and Shooter, 1993 ). This elevated BDNF expression corresponds with increased BDNF anterograde transport in the sciatic nerve. Preliminary reports suggest that, in addition to
trkA-positive sensory neurons, trkB- and trkC-positive sensory neurons
also express BDNF mRNA after nerve injury (Averill et al., 1997 ). In
agreement with previous reports (Ernfors et al., 1990 ), we found that
normal, and also axotomized, spinal cord motor neurons did not express
detectable BDNF mRNA by in situ hybridization. However,
others have reported that BDNF mRNA is increased in axotomized rat
facial motor neurons 1 d after axotomy (Kobayashi et al., 1996 ),
which may reflect an inherent difference between spinal and brainstem
motor neurons.
Anterograde transport in the sciatic nerve appears to be specific for
BDNF among the neurotrophins studied. NGF accumulated only in the
distal nerve segment, indicating only retrograde transport of
endogenous NGF, as expected from the lack of NGF mRNA in the adult rat
spinal cord and DRG neurons (Korsching and Thoenen, 1985 ; Kashiba et
al., 1997 ). NT-3 levels did not specifically increase in any nerve
segments after double ligation, consistent with the lack of NT-3 mRNA
in the adult rat DRG and spinal cord (Ernfors et al., 1990 ; Kashiba et
al., 1997 ) (J. R. Tonra and P. S. DiStefano, unpublished
data). The increased NT-3 protein levels after ligation compared with
baseline may represent local production, although NT-3 mRNA expression
has been reported to decrease by ~50% 1 d after sciatic nerve
transection (Funakoshi et al., 1993 ).
Targets of BDNF action
There are three possible targets for anterogradely transported
BDNF in the sciatic nerve: peripheral target tissues, Schwann cells in
the nerve, and peripherally projecting neurons. BDNF may be released at
the axon terminals in the skin and muscle, serving as a
neurotransmitter on responsive peripheral target tissues. Several
observations suggest a role for BDNF in neurotransmission. In culture,
BDNF modulates the excitability of developing neuromuscular synapses
(Lohof et al., 1993 ) and regulates postsynaptic activity in hippocampal
neurons (Kang and Schuman, 1995 ; Levine et al., 1995 ) via trkB
receptors localized in hippocampal postsynaptic densities (Wu et al.,
1996 ). BDNF is present in the synaptosomal fraction isolated from adult
rat cortex (Fawcett et al., 1997 ) and shows activity-dependent release
(Androutsellis-Theotokis et al., 1996 ). In spinal cord, BDNF is
localized in vesicles within axon terminals in the superficial dorsal
horn (Michael et al., 1997 ). BDNF immunoreactivity in dorsal horn can
be abolished by rhizotomy (Zhou and Rush, 1996 ) (Tonra and DiStefano,
unpublished observations), suggesting that it arises from primary
nociceptive neurons in the DRG and, therefore, may be involved in
responses to painful stimuli.
The targets of anterogradely transported BDNF are likely to change in
pathological states, such as peripheral nerve trauma. A role for BDNF
after nerve injury is supported by the increased BDNF expression in
injured sensory neurons and accumulation in the tip of the proximal
nerve stump. It is possible that anterogradely transported BDNF may be
released at the site of axon damage to support peripheral neurons that
have lost target-derived trophic factors. The calculated concentration
of BDNF proximal to a ligature (~2 × 10 9
M) is likely to activate receptors for BDNF
(Kd,
10 10-10 11 M)
(Chao, 1994 ; Chao and Hempstead, 1995 ). Acheson et al. (1995) have
shown a paracrine and autocrine requirement for BDNF in the survival of
adult sensory neurons in vitro, so BDNF released from damaged axons may prevent the axotomy-induced death of a population of
DRG neurons. BDNF released from sensory neurons may also provide trophic support to damaged motor neurons (DiStefano et al., 1992 ; Yan
et al., 1992 ; Friedman et al., 1995 ) that express the catalytic isoform
of trkB (Koliatsos et al., 1993 ). Because levels of anterogradely transported BDNF return to normal by 2 d, the regenerating axons may find an alternative source of BDNF in Schwann cells in the distal
stump, which show increased synthesis of BDNF at later times after
nerve lesion (Meyer et al., 1992 ; Funakoshi et al., 1993 ).
A role for BDNF in the response to nerve injury is further suggested by
increased receptor-mediated retrograde transport of exogenous
125I-BDNF to sensory and motor neurons 1 d after
sciatic nerve crush or dorsal rhizotomy (DiStefano and Curtis, 1994 )
(R. Curtis, J. R. Tonra and P. S. DiStefano, unpublished observation).
This is thought to be mediated by a generalized increase in anterograde and retrograde transport capacity of injured neurons, possibly related
to increased expression of axonal transport motor proteins (Su et al.,
1997 ). Increased synthesis and anterograde transport of BDNF by sensory
neurons after nerve injury could be part of a coordinated program to
enhance the survival of axotomized neurons. This may be a general
response of sensory neurons to injury, because increased BDNF
anterograde transport also occurs after rhizotomy.
Anterogradely transported BDNF may also aid in nerve regeneration.
Schwann cells increase their expression of low-affinity neurotrophin
receptor (LNR) and a truncated noncatalytic form of trkB after nerve
injury (Funakoshi et al., 1993 ). Anterogradely transported BDNF
released by damaged neurons may bind to these receptors expressed on
Schwann cells and serve as a localized source of trophic support for
regenerating neurons or guide axonal elongation, as proposed previously
for NGF (Johnson et al., 1988 ; Frisén et al., 1993 ). BDNF
released in nerve may also act on Schwann cells expressing LNR after
nerve injury. NGF, BDNF, and NT-3 all signal through this receptor via
the sphingomyelin-ceramide pathway (Dobrowsky et al., 1995 ). Because
LNR signaling through the ceramide pathway promotes cell death
(Rabizadeh et al., 1993 ; Casaccia-Bonnefil et al., 1996 ), axonal BDNF
may help control Schwann cell numbers after peripheral nerve injury.
BDNF released from axons may also regulate Schwann cell migration after
nerve injury, an effect induced by NGF that can be inhibited by
antibodies to LNR (Anton et al., 1994 ).
In conclusion, BDNF anterograde transport by sensory neurons is
dramatically increased after damage to the peripheral or central axons
of sensory neurons. The specificity of this effect for BDNF anterograde
transport suggests an important role for this neurotrophin in the
functioning of the peripheral nervous system and the response to nerve
injury.
 |
FOOTNOTES |
Received Dec. 22, 1997; revised Feb. 23, 1998; accepted March 17, 1998.
We are grateful to Karen Garcia, Elizabeth Zlotchenko, and Carl Jackson
for their excellent technical assistance and to Evan Burrows and
Claudia Murphy for photographic assistance. We thank Dr. Eugene M. Johnson Jr, Dr. Lorne M. Mendell, and Dr. J. Kessler for antibodies and
Dr. Peter C. Maisonpierre for the BDNF mRNA probe. We also thank Dr.
Jocelyn Holash and Dr. Sue Bodine for their helpful discussion of the
results.
Correspondence should be addressed to Dr. James R. Tonra, Regeneron
Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY
10591.
Drs. Curtis, Lindsay, and DiStefano, and T. Nguyen's present address:
Millennium Pharmaceuticals, Inc., 640 Memorial Drive, Cambridge, MA
02139-4815.
 |
REFERENCES |
-
Acheson A,
Conover JC,
Fandl JP,
DeChiara TM,
Russell M,
Thadani A,
Squinto SP,
Yancopoulos GD,
Lindsay RM
(1995)
A BDNF autocrine loop in adult sensory neurons prevents cell death.
Nature
374:450-453[Medline].
-
Altar CA,
Cai N,
Bliven T,
Juhasz M,
Conner JM,
Acheson A,
Lindsay RM,
Wiegand SJ
(1997)
Anterograde transport of brain-derived neurotrophic factor and its role in the brain.
Nature
389:856-860[Medline].
-
Anderson KD,
Alderson RF,
Altar CA,
DiStefano PS,
Corcoran TL,
Lindsay RM,
Wiegand SJ
(1995)
Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophins receptors.
J Comp Neurol
357:296-317[Web of Science][Medline].
-
Androutsellis-Theotokis A,
McCormack WJ,
Bradford HF,
Stern GM,
Pliego-Rivero FB
(1996)
The depolarization-induced release of 125I-BDNF from brain tissue.
Brain Res
743:40-48[Web of Science][Medline].
-
Anton ES,
Weskamp G,
Reichardt LF,
Matthew WD
(1994)
Nerve growth factor and its low-affinity receptor promote Schwann cell migration.
Proc Natl Acad Sci USA
91:2795-2799[Abstract/Free Full Text].
-
Averill S,
Michael GJ,
Shortland PJ,
Priestley JV
(1997)
BDNF increases in large diameter dorsal root ganglion cells and in their central projections following peripheral axotomy.
Soc Neurosci Abstr
23:134.8.
-
Barbacid M
(1994)
The trk family of neurotrophin receptors.
J Neurobiol
25:1386-1403[Web of Science][Medline].
-
Ben-Jonathan N,
Maxson RE,
Ochs S
(1978)
Fast axoplasmic transport of noradrenaline and dopamine in mammalian peripheral nerve.
J Physiol (Lond)
281:315-324[Abstract/Free Full Text].
-
Bianchi LM,
Conover JC,
Fritzsch B,
DeChiara T,
Lindsay RM,
Yancopoulos GD
(1996)
Degeneration of vestibular neurons in late embryogenesis of both heterozygous and homozygous BDNF null mutant mice.
Development
122:1965-1973[Abstract].
-
Casaccia-Bonnefil P,
Carter BD,
Dobrowsky RT,
Chao MV
(1996)
Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75.
Nature
383:716-719[Medline].
-
Chao MV
(1994)
The p75 neurotrophin receptor.
J Neurobiol
25:1373-1385[Web of Science][Medline].
-
Chao MV,
Hempstead BL
(1995)
p75 and Trk: a two-receptor system.
Trends Neurosci
18:321-326[Web of Science][Medline].
-
Conner JM,
Lauterborn JC,
Yan Q,
Gall CM,
Varon S
(1997)
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport.
J Neurosci
17:2295-2313[Abstract/Free Full Text].
-
Curtis R,
DiStefano PS
(1994)
Neurotrophic factors, retrograde axonal transport and cell signalling.
Trends Cell Biol
4:383-386.[Medline]
-
Curtis R,
Adryan KM,
Stark JL,
Park JS,
Compton DL,
Weskamp G,
Huber LJ,
Chao MV,
Jaenisch R,
Lee KF,
Lindsay RM,
DiStefano PS
(1995)
Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins.
Neuron
14:1201-1211[Web of Science][Medline].
-
DiStefano PS,
Curtis R
(1994)
Receptor mediated retrograde axonal transport of neurotrophic factors is increased after peripheral nerve injury.
Prog Brain Res
103:35-42[Web of Science][Medline].
-
DiStefano PS,
Friedman B,
Radziejewski C,
Alexander C,
Boland P,
Schick CM,
Lindsay RM,
Wiegand SJ
(1992)
The neurotrophins BDNF, NT-3 and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons.
Neuron
8:983-993[Web of Science][Medline].
-
Dobrowsky RT,
Jenkins GM,
Hannun YA
(1995)
Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors.
J Biol Chem
270:22135-22142[Abstract/Free Full Text].
-
Dumoulin FL,
Raivich G,
Streit WJ,
Kreutzberg GW
(1991)
Differential regulation of calcitonin gene-related peptide (CGRP) in regenerating rat facial nucleus and dorsal root ganglion.
Eur J Neurosci
3:338-342[Web of Science][Medline].
-
Ernfors P,
Wetmore C,
Olson L,
Persson H
(1990)
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family.
Neuron
5:511-526[Web of Science][Medline].
-
Fawcett JP,
Aloyz R,
McLean JH,
Pareek S,
Miller FD,
McPherson PS,
Murphy RA
(1997)
Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes.
J Biol Chem
272:8837-8840[Abstract/Free Full Text].
-
Friedman B,
Scherer SS,
Rudge JS,
Helgren M,
Morissey D,
McClain J,
Wang D-Y,
Wiegand SJ,
Furth ME,
Lindsay RM,
Ip NY
(1992)
Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo.
Neuron
9:295-305[Web of Science][Medline].
-
Friedman B,
Kleinfeld D,
Ip NY,
Verge VMK,
Moulton R,
Boland P,
Zlotchenko E,
Lindsay RM,
Liu L
(1995)
BDNF and NT-4/5 exert neurotrophic influences on injured adult spinal motor neurons.
J Neurosci
15:1044-1056[Abstract].
-
Frisén J,
Verge VMK,
Fried K,
Risling M,
Persson H,
Trotter J,
Hökfelt T,
Lindholm D
(1993)
Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous system.
Proc Natl Acad Sci USA
90:4971-4975[Abstract/Free Full Text].
-
Funakoshi H,
Frisén J,
Barbany G,
Timmusk T,
Zachrisson O,
Verge VMK,
Persson H
(1993)
Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve.
J Cell Biol
123:455-465[Abstract/Free Full Text].
-
Henderson CE,
Camu W,
Mettling C,
Gouin A,
Poulsen K,
Karihaloo M,
Rullamas J,
Evans T,
McMahon SB,
Armanini MP
(1993)
Neurotrophins promote motor neuron survival and are present in embryonic limb bud.
Nature
363:266-270[Medline].
-
Ishida-Yamamoto A,
Senba E,
Tohyama M
(1989)
Distribution and fine structure of calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat skin.
Brain Res
491:93-101[Web of Science][Medline].
-
Jessell T,
Tsunoo A,
Kanazawa I,
Otsuka M
(1979)
Substance P: depletion in the dorsal horn of rat spinal cord after section of the peripheral processes of primary sensory neurons.
Brain Res
168:247-259[Web of Science][Medline].
-
Johnson Jr EM,
Taniuchi M,
Clark HB,
Springer JE,
Koh S,
Tayrien MW,
Loy R
(1987)
Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and CNS.
J Neurosci
7:923-929[Abstract].
-
Johnson Jr EM,
Taniuchi M,
DiStefano PS
(1988)
Expression and possible function of nerve growth factor receptors on Schwann cells.
Trends Neurosci
11:299-304[Web of Science][Medline].
-
Johnson F,
Hohmann SE,
DiStefano PS,
Bottjer SW
(1997)
Neurotrophins suppress apoptosis induced by deafferentation of an avian motor-cortical region.
J Neurosci
17:2101-2111[Abstract/Free Full Text].
-
Kang H,
Schuman EM
(1995)
Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus.
Science
267:1658-1662[Abstract/Free Full Text].
-
Kashiba H,
Ueda Y,
Ueyama T,
Nemoto K,
Senba E
(1997)
Relationship between BDNF- and trk-expressing neurones in rat dorsal root ganglion: an analysis by in situ hybridization.
NeuroReport
8:1229-1234[Web of Science][Medline].
-
Kobayashi NR,
Bedard AM,
Hincke MT,
Tetzlaff W
(1996)
Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy.
Eur J Neurosci
8:1018-1029[Web of Science][Medline].
-
Koliatsos VE,
Clatterbuck RE,
Winslow JW,
Cayoutte MH,
Price DL
(1993)
Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo.
Neuron
10:359-367[Web of Science][Medline].
-
Korsching S,
Thoenen H
(1985)
Nerve growth factor supply for sensory neurons: site of origin and competition with the sympathetic nervous system.
Neurosci Lett
54:201-205[Web of Science][Medline].
-
Kruger L,
Sampogna SL,
Rodin BE,
Clague J,
Brecha N,
Yeh Y
(1985)
Thin-fiber cutaneous innervation and its intraepidermal contribution studied by labeling methods and neurotoxin treatment in rats.
Somatosens Res
2:335-356[Web of Science][Medline].
-
Levine ES,
Dreyfus CF,
Black IB,
Plummer MR
(1995)
Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors.
Proc Natl Acad Sci USA
92:8074-8077[Abstract/Free Full Text].
-
Lohof AM,
Ip NY,
Poo MM
(1993)
Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF.
Nature
363:350-353[Medline].
-
Maisonpierre PC,
Le Beau MM,
Espinosa III R,
Ip NY,
Belluscio L,
De La Monte SM,
Squinto S,
Furth ME,
Yancopoulos GD
(1991)
Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations.
Genomics
10:558-568[Web of Science][Medline].
-
Meyer M,
Matsuoka I,
Wetmore C,
Olson L,
Thoenen H
(1992)
Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA.
J Cell Biol
119:45-54[Abstract/Free Full Text].
-
Michael GJ,
Averill S,
Nitkunan A,
Rattray M,
Bennett DLH,
Yan Q,
Priestley JV
(1997)
Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in tyrosine kinase A-expressing dorsal root ganglion cells and in their central terminations within the spinal cord.
J Neurosci
17:8476-8490[Abstract/Free Full Text].
-
Palmatier MA,
Hartman BK,
Johnson Jr EM
(1984)
Demonstration of retrogradely transported endogenous nerve growth factor in axons of sympathetic neurons.
J Neurosci
4:751-756[Abstract].
-
Rabizadeh S,
Oh J,
Zhong LT,
Yang J,
Bitler CM,
Butcher LL,
Bredesen DE
(1993)
Induction of apoptosis by the low-affinity NGF receptor.
Science
261:345-348[Abstract/Free Full Text].
-
Radka SF,
Holst PA,
Fritsche M,
Altar CA
(1996)
Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay.
Brain Res
709:122-130[Web of Science][Medline].
-
Ranish N,
Ochs S
(1972)
Fast axoplasmic transport of acetylcholinesterase in mammalian nerve fibers.
J Neurochem
19:2641-2649[Web of Science][Medline].
-
Schecterson LC,
Bothwell M
(1992)
Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons.
Neuron
9:449-463[Web of Science][Medline].
-
Sebert ME,
Shooter EM
(1993)
Expression of mRNA for neurotrophic factors and their receptors in the rat dorsal root ganglion and sciatic nerve following nerve injury.
J Neurosci Res
36:357-367[Web of Science][Medline].
-
Snider WD
(1994)
Functions of the neurotrophins during nervous system development: what the knockouts are teaching us.
Cell
77:627-638[Web of Science][Medline].
-
Su QN,
Namikawa K,
Toki H,
Kiyama H
(1997)
Differential display reveals transcriptional upregulation of the motor molecules for both anterograde and retrograde axonal transport during nerve regeneration.
Eur J Neurosci
9:1542-1547[Web of Science][Medline].
-
Swett JE,
Torigoe Y,
Elie VR,
Bourassa CM,
Miller PG
(1991)
Sensory neurons of the rat sciatic nerve.
Exp Neurol
114:82-103[Web of Science][Medline].
-
von Bartheld CS,
Byers MR,
Williams R,
Bothwell M
(1996)
Anterograde transport of neurotrophins and axodendritic transfer in the developing visual system.
Nature
379:830-833[Medline].
-
Wetmore C,
Olson L
(1995)
Neuronal and nonneuronal expression of neurotrophins and their receptors in sensory and sympathetic ganglia suggest new intercellular trophic interactions.
J Comp Neurol
353:143-159[Web of Science][Medline].
-
Wong V,
Kessler JA
(1987)
Solubilization of a membrane factor that stimulates levels of substance P and choline acetyltransferase in sympathetic neurons.
Proc Natl Acad Sci USA
84:8726-8729[Abstract/Free Full Text].
-
Wu K,
Xu JL,
Suen PC,
Levine ES,
Lin SY,
Huang YY,
Mount HTJ,
Black IB
(1996)
Functional trkB neurotophin receptors are intrinsic components of the adult brain postsynaptic density.
Mol Brain Res
43:286-290[Medline].
-
Yan Q,
Elliott J,
Snider WD
(1992)
Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death.
Nature
360:753-755[Medline].
-
Zhou XF,
Rush RA
(1996)
Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons.
Neuroscience
74:945-953[Web of Science][Medline].
Copyright © 1998 Society for Neuroscience 0270-6474/98/18114374-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. Wu, W. Huang, P. M. Richardson, J. V. Priestley, and M. Liu
TRPC4 in Rat Dorsal Root Ganglion Neurons Is Increased after Nerve Injury and Is Necessary for Neurite Outgrowth
J. Biol. Chem.,
January 4, 2008;
283(1):
416 - 426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Ng, L. Chen, W. Mandemakers, J. M. Cosgaya, and J. R. Chan
Anterograde Transport and Secretion of Brain-Derived Neurotrophic Factor along Sensory Axons Promote Schwann Cell Myelination
J. Neurosci.,
July 11, 2007;
27(28):
7597 - 7603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Byrne, R. M. Stuart, C. Fakhry, M. Lehar, and P. W. Flint
An Electrophysiologic Model for Functional Assessment of Effects of Neurotrophic Factors on Facial Nerve Reinnervation
Arch Facial Plast Surg,
March 1, 2005;
7(2):
114 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Obata, H. Yamanaka, Y. Dai, T. Tachibana, T. Fukuoka, A. Tokunaga, H. Yoshikawa, and K. Noguchi
Differential Activation of Extracellular Signal-Regulated Protein Kinase in Primary Afferent Neurons Regulates Brain-Derived Neurotrophic Factor Expression after Peripheral Inflammation and Nerve Injury
J. Neurosci.,
May 15, 2003;
23(10):
4117 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-J. Song, C. Vizcarra, D.-S. Xu, R. L. Rupert, and Z.-N. Wong
Hyperalgesia and Neural Excitability Following Injuries to Central and Peripheral Branches of Axons and Somata of Dorsal Root Ganglion Neurons
J Neurophysiol,
April 1, 2003;
89(4):
2185 - 2193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Stokely, S. T. Brady, and T. Yorio
Effects of Endothelin-1 on Components of Anterograde Axonal Transport in Optic Nerve
Invest. Ophthalmol. Vis. Sci.,
October 1, 2002;
43(10):
3223 - 3230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Xiao, Q.-H. Huang, F.-X. Zhang, L. Bao, Y.-J. Lu, C. Guo, L. Yang, W.-J. Huang, G. Fu, S.-H. Xu, et al.
Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain
PNAS,
June 11, 2002;
99(12):
8360 - 8365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-H. Chen, W. G. Tourtellotte, and E. Frank
Muscle Spindle-Derived Neurotrophin 3 Regulates Synaptic Connectivity between Muscle Sensory and Motor Neurons
J. Neurosci.,
May 1, 2002;
22(9):
3512 - 3519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schafers, C. Geis, D. Brors, T. L. Yaksh, and C. Sommer
Anterograde Transport of Tumor Necrosis Factor-alpha in the Intact and Injured Rat Sciatic Nerve
J. Neurosci.,
January 15, 2002;
22(2):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stadelmann, M. Kerschensteiner, T. Misgeld, W. Bruck, R. Hohlfeld, and H. Lassmann
BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?
Brain,
January 1, 2002;
125(1):
75 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Sleeper, T. R. Cummins, S. D. Dib-Hajj, W. Hormuzdiar, L. Tyrrell, S. G. Waxman, and J. A. Black
Changes in Expression of Two Tetrodotoxin-Resistant Sodium Channels and Their Currents in Dorsal Root Ganglion Neurons after Sciatic Nerve Injury But Not Rhizotomy
J. Neurosci.,
October 1, 2000;
20(19):
7279 - 7289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. N. Thompson, D. L. H. Bennett, B. J. Kerr, E. J. Bradbury, and S. B. McMahon
Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord
PNAS,
July 6, 1999;
96(14):
7714 - 7718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pezet, B. Onteniente, G. Grannec, and B. Calvino
Chronic Pain is Associated with Increased TrkA Immunoreactivity in Spinoreticular Neurons
J. Neurosci.,
July 1, 1999;
19(13):
5482 - 5492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Kerr, E. J. Bradbury, D. L. H. Bennett, P. M. Trivedi, P. Dassan, J. French, D. B. Shelton, S. B. McMahon, and S. W. N. Thompson
Brain-Derived Neurotrophic Factor Modulates Nociceptive Sensory Inputs and NMDA-Evoked Responses in the Rat Spinal Cord
J. Neurosci.,
June 15, 1999;
19(12):
5138 - 5148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Murphy, L. S. Borthwick, R. S. Johnston, G. Kuchel, and P. M. Richardson
Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons
J. Neurosci.,
May 15, 1999;
19(10):
3791 - 3800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chang and S. V. Popov
Long-range signaling within growing neurites mediated by neurotrophin-3
PNAS,
March 30, 1999;
96(7):
4095 - 4100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martinez, S. Alcantara, V. Borrell, J. A. Del Rio, J. Blasi, R. Otal, N. Campos, A. Boronat, M. Barbacid, I. Silos-Santiago, et al.
TrkB and TrkC Signaling Are Required for Maturation and Synaptogenesis of Hippocampal Connections
J. Neurosci.,
September 15, 1998;
18(18):
7336 - 7350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|